Indian court directs forensic auditor appointment in Daiichi-Fortis case, IHH says
FTSE 100 falls for sixth day in a row as consumer stocks weigh
Ftse 100 Set To Snap Six: day losing streak as miners gain
Brief: AstraZeneca Says Enhertu Improved PFS In 1L HER2m Lung Cancer
Table: Daiichi Sankyo -Q1 group results (IFRS)
Table: Daiichi Sankyo -2025/26 parent results
Table: Daiichi Sankyo -2025/26 group results (IFRS)
Brief: FDA Says American Regent Recalled One Lot Of Papaverine Hydrochloride Injection
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports (updated)
Brief: AstraZeneca Spokesperson Says Co in Discussions With NHS, NICE To Support Access To Enhertu
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports
Brief: Astrazeneca, Daiichi Near UK Price Deal For Breast Cancer Drug-Bloomberg News
Focus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
Notice Regarding Conclusion Of A Money Loan Agreement With Financial Covenants
Brief: Daiichi Sankyo - Won Approval To Market 'Vanflyta (Quizartinib)' In China For First-Line Treatment Of Flt3-Itd Mutation-Positive Acute Myeloid Leukemia
Brief: Daiichi Sankyo Concludes pCPA Letter Of Intent For Vanflyta®
Brief: AstraZeneca Says Datroway Approved In US For 1L Triple-Negative BC
Brief: EMA's CHMP Recommends Extension To Marketing Authorisation For Wegovy
Brief: FDA Approves Daiichi Sankyo's fam-trastuzumab deruxtecan-nxki For Two Breast Cancer Indications